Glassman, Robert Howard

Publications

Sort by

Co-Author Network

Biomarkers in early cancer drug development: limited utility. Clinical pharmacology and therapeutics. 2009 Review GET IT
Times cited: 18
Wall Street's perspective on oncology drug development. Clinical advances in hematology & oncology : H&O. 2007 Academic Article GET IT
Biotechnology: identifying advances from the hype. Nature reviews. Drug discovery. 2004 Review GET IT
Times cited: 34
v-Crk, an effector of the nerve growth factor signaling pathway, delays apoptotic cell death in neurotrophin-deprived PC12 cells. Cell death and differentiation. 1997 Academic Article GET IT
Times cited: 8
Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways. Molecular and cellular biology. 1994 Academic Article GET IT
Times cited: 74